The novel coronavirus pneumonia vaccine has been approved by the United States to expand the use range. People aged between 12 and 15 can be vaccinated.

In May 10th, the US Food and Drug Administration approved the expanded use of the New Coronavirus pneumonia (COVID-19) vaccine jointly developed by the US Pfizer Inc (Pfizer) and the German biodiesel (BioNTech)

.

It can be used urgently among people aged 12 to 15

.

Pfizer vaccine was approved by the United States in December 2020 for emergency use in people aged 16 or above

.

The U.S

.

Food and Drug Administration said in a statement on the 10th that the Pfizer vaccine meets the statutory standards, and the known and potential benefits for people aged 12 or above outweigh the risks, so it has decided to expand the scope of authorization for emergency use of the vaccine

.

People aged 12 to 15 also need two doses of Pfizer vaccine, 21 days apart

.

It is estimated that the center for Disease Control and prevention will announce its approval on the 12th, and people aged 12 to 15 can be vaccinated as soon as the 13th

.

President Joe Biden described the FDA’s decision as an important step for Americans to return to normal life

.

The picture shows that on May 8, 2021, people in Los Angeles were vaccinated with Pfizer’s novel coronavirus vaccine( Pfizer released the preliminary results of a vaccine clinical trial on more than 2200 volunteers aged 12 to 15 in March, which showed that no one who completed two doses of the vaccine was infected with the new coronavirus

.

According to the vaccine safety assessment released by the food and drug administration, the adverse reactions reported by these volunteers after vaccination mainly included pain at the injection site, fatigue, headache, muscle pain, joint pain and fever, which usually disappeared in one to three days

.

The FDA stressed that people with severe allergic symptoms, including allergic reactions to any component of Pfizer vaccine, should not be vaccinated..

.